2Spandorfer SD, Goldstein J, Navarro J,et al. Difficult embryotransfer has a negative impact on the outcome of in vitrofertilization. Fertil Steril, 2003,79(3):654-5.
3Bossmar T, Akerlund M,Fantoni G, et al. Receptors for andmyometrial responses to oxytocin and vasopressin in pretermand term human pregnancy: effects of the oxytocin antagonistatosiban. Am J Obstet Gynecol, 1994,171(6):1634-42.
4Akerlund M, Melin P, Maggi M. Potential use of oxytocin andvasopressin Via antagonists in the treatment of preterm la-bor and primary dysmenorrhoea. Adv Exp Med Biol, 1995,395:595-600.
5Pierzynski P,Reinheimer TM, Kuczynski W. Oxytocinantagonists may improve infertility treatment. Fertil Steril,2007,88(l):213.el9-22.
6Lemaster JW, Seals RC, Hopkins FM, et al. Effects ofadministration of oxytocin on embryonic survival in progesto-gen supplemented cattle. Prostaglandins Other Lipid Mediat,1999,57(4):259-68.
7Fanchin R, Righini C, Olivennes F,et al. Uterine contractionsat the time of embryo transfer alter pregnancy rates after invitro fertilization. Hum Reprod, 1998,13(7):1968-74.
8Moon HS, Park HS, Lee JO, et al. Treatment with piroxicambefore embryo transfer increases the pregnancy rate after in-vitro fertilization and embryo transfer. Fertil Steril, 2004,82(4):816-20.
9Tsatsaris V, Carbonne B, Cabrol D. Atosiban for pretermlabour. Drugs, 2004, 64(4):375-82.
10Ingemarsson I, Lamonf RF. An update on the controversiesof tocolytic therapy for the prevention of preterm birth. ActaObstet Gynecol Scand,2003,82(1):1-9.
